Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04761055 · ClinicalTrials.gov registry record · NA
Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer
A NA study of Breast Screening, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 309
- Enrollment target
- 2
- Study locations
NCT04761055 is a NA study of Breast Screening that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 309 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT04761055, a NA study of Breast Screening, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 309 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will test the iBreastExam device to find out whether it can detect a mass or lump in the breast as accurately as a routine breast cancer screening examination. The iBreastExam is a handheld device that performs a painless electronic palpation (examination by touch) of the breast. The device is designed to detect breast abnormalities that may require breast imaging and additional clinical examination by a nurse or doctor. The iBreastExam device creates a color map of the breast, with red spots indicating areas that may be abnormal.
Conditions Studied
Interventions
- OTHER Clinical Breast exam (CBE)
- DEVICE iBreastExam device
- DIAGNOSTIC_TEST mammogram
Study Locations (2)
New York
- MSK at Ralph Lauren (All Protocol Activities) - New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 309 participants |
| Start Date | 2021-01-29 |
| Est. Completion | 2025-08-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04761055
The ClinicalTrials.gov registry entry for NCT04761055 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 309 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Screening appearing as the primary indexed condition, and to 3 interventions - of which Clinical Breast exam (CBE) is the first listed.
NCT04761055 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04761055 about?
NCT04761055 is a clinical study titled "Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer". This study will test the iBreastExam device to find out whether it can detect a mass or lump in the breast as accurately as a routine breast cancer screening examination. The iBreastExam is a handheld device that performs a painless electronic palpation (examination by touch) of the breast. The dev...
What is the current status of trial NCT04761055?
This trial is currently completed. It is a NA study. The enrollment target is 309 participants. The study started on 2021-01-29. Estimated completion is 2025-08-19.
What conditions does trial NCT04761055 study?
This clinical trial studies the following conditions: Breast Screening.
What interventions are being tested in trial NCT04761055?
The interventions under investigation include: Clinical Breast exam (CBE) (OTHER), iBreastExam device (DEVICE), mammogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04761055?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04761055 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.